BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33300880)

  • 1. [Intense pulsed light treatment for hidradenitis suppurativa: a within-person randomized controlled trial].
    Andersen PL; Riis PT; Thorlacius L; Sigsgaard V; Nielsen CW; Chafranska L; Westergaard C; Jemec GB; Saunte DM
    Eur J Dermatol; 2020 Dec; 30(6):723-729. PubMed ID: 33300880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study.
    Highton L; Chan WY; Khwaja N; Laitung JKG
    Plast Reconstr Surg; 2011 Aug; 128(2):459-466. PubMed ID: 21788837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasers and Intense Pulsed Light Hidradenitis Suppurativa.
    Saunte DM; Lapins J
    Dermatol Clin; 2016 Jan; 34(1):111-9. PubMed ID: 26617364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of laser hair removal in hidradenitis suppurativa: A systematic review and meta-analysis.
    Shipman WD; Williams MN; Suozzi KC; Eisenstein AS; Dover JS
    Lasers Surg Med; 2024 Jul; 56(5):425-436. PubMed ID: 38769894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser and Light-Based Treatment Modalities for the Management of Hidradenitis Suppurativa.
    Lyons AB; Townsend SM; Turk D; Narla S; Baah N; Hamzavi IH
    Am J Clin Dermatol; 2020 Apr; 21(2):237-243. PubMed ID: 31845121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa: A Parallel-Design Double-Blind Trial.
    Ben Abdallah H; Bregnhøj A; Emmanuel T; Ghatnekar G; Johansen C; Iversen L
    JAMA Dermatol; 2024 Jan; 160(1):63-70. PubMed ID: 38055242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
    Kimball AB; Ganguli A; Fleischer A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF).
    Wilden S; Friis M; Tuettenberg A; Staubach-Renz P; Wegner J; Grabbe S; von Stebut E
    J Dermatolog Treat; 2021 Aug; 32(5):530-537. PubMed ID: 31609667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of radiofrequency in the treatment of hidradenitis suppurativa; a systematic review.
    Nilforoushzadeh MA; Heidari N; Heidari A; Ghane Y; Hosseini S; Lotfi Z; Jaffary F; Nobari MN; Aghamiri ZS; Nobari NN
    Lasers Med Sci; 2024 May; 39(1):139. PubMed ID: 38795173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
    Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC
    Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
    Zouboulis CC; Bechara FG; Fritz K; Goebeler M; Hetzer FH; Just E; Kirsten N; Kokolakis G; Kurzen H; Nikolakis G; Pinter A; Podda M; Rosinski K; Schneider-Burrus S; Taube KM; Volz T; Winkler T; Kristandt A; Presser D; Zouboulis VA
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):868-889. PubMed ID: 38770982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study.
    Fadel MA; Tawfik AA
    Clin Exp Dermatol; 2015 Mar; 40(2):116-22. PubMed ID: 25262788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CME Dermatology 23: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021; 110(7):363-372. PubMed ID: 34019444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser and intense pulsed light in the treatment of hidradenitis suppurativa.
    Saunte DML; Jemec GBE
    Clin Dermatol; 2023; 41(5):628-638. PubMed ID: 37659574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CME Dermatology 23/Answers: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021 Jun; 110(8):471-472. PubMed ID: 34107755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
    Daoud M; Suppa M; Benhadou F; Daxhelet M; Njimi H; White J; Jemec G; Del Marmol V
    Front Med (Lausanne); 2023; 10():1145152. PubMed ID: 37138732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
    Kimball AB; Sobell JM; Zouboulis CC; Gu Y; Williams DA; Sundaram M; Teixeira HD; Jemec GB
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):989-94. PubMed ID: 26201313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.